Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Operating Expenses (2010 - 2026)

Nomad Power Solutions (NMAD) posted Operating Expenses of $2.3 million for Q2 2026, up 28.8% on a QoQ basis from $1.8 million in Q4 2025, and up 203.29% year-over-year from $774809.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Operating Expenses (2010 - 2026) Analysis & Trends

Nomad Power Solutions has reported Operating Expenses for 17 years, with the latest figure at $2.3 million in Q2 2026.

  • On a quarterly basis, Operating Expenses rose 203.29% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $6.8 million, a 119.28% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, up 42.96% from the prior year.
  • Operating Expenses was $2.3 million for Q2 2026 at Nomad Power Solutions, up from $1.8 million in the prior quarter.
  • The five-year high for Operating Expenses was $2.3 million in Q2 2026, with the low at $613497.0 in Q4 2024.
  • Average Operating Expenses over 5 years is $1.3 million, with a median of $1.4 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2026: Operating Expenses tumbled 40.2% in 2024, then jumped 203.29% in 2026.
  • Over 5 years, Operating Expenses stood at $1.6 million in 2022, then sank by 37.16% to $1.0 million in 2023, then slumped by 40.2% to $613497.0 in 2024, then soared by 197.4% to $1.8 million in 2025, then advanced by 28.8% to $2.3 million in 2026.
  • The last three Operating Expenses figures came in at $2.3 million (Q2 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.05 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 367.83 Mn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 2.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.35 Mn
Dec 31, 2025 1.82 Mn
Sep 30, 2025 1.80 Mn
Jun 30, 2025 774,809.00
Mar 31, 2025 706,940.00
Dec 31, 2024 613,497.00
Sep 30, 2024 983,257.00
Jun 30, 2024 1.01 Mn
Mar 31, 2024 966,879.00
Dec 31, 2023 1.03 Mn
Sep 30, 2023 1.02 Mn
Jun 30, 2023 1.67 Mn
Mar 31, 2023 1.37 Mn
Dec 31, 2022 1.63 Mn
Sep 30, 2022 1.48 Mn
Jun 30, 2022 1.55 Mn
Mar 31, 2022 1.65 Mn
Dec 31, 2021 2.02 Mn
Sep 30, 2021 1.24 Mn
Jun 30, 2021 1.73 Mn